Stomach cancer study seeks best Follow-Up care after complete response
NCT ID NCT07161453
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 27 times
Summary
This study looks at 500 adults with stomach or gastroesophageal junction cancer who had surgery after chemotherapy and immunotherapy, and whose tumors were completely gone. Researchers want to see which post-surgery treatment plan works best to keep the cancer from coming back. Participants will receive either standard chemotherapy or a combination of chemotherapy and an immunotherapy drug, and their health will be tracked over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.